34
DAFTAR PUSTAKA
Ali, A.H., Belachew, T., Yami, A., Ayen, W.Y., 2013. Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study. PLoS ONE 8(5):2.
Bayupurnama, P., 2009. Hepatotoksisitas Imbas Obat. Dalam: Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., eds. Buku Ajar Ilmu
Penyakit Dalam. Jilid 1. Edisi V. Jakarta: Interna Publishing, 708-710.
Forget, E.J., Menzies, D., 2006. Adverse Reactions to First-Line Antituberculosis Drugs. Expert Opin. Drug Saf. 5(2): 231-249. Available from: http://informahealthcare.com/doi/abs/10.1517/14740338.5.2.231 [Accessed 1 May 2015].
Istiantoro, Y.H., Setiabudy, R., 2007. Tuberkulostatik dan Leprostatik. Dalam: Gunawan, S.G., Setiabudy, R., Nafrialdi, Elysabeth, eds. Farmakologi dan
Terapi. Edisi 5. Jakarta: Badan Penerbit FKUI, 613-620.
Kementrian Kesehatan Republik Indonesia, 2014. Pedoman Nasional
Pengendalian Tuberkulosis. Direktorat Jendral Pengendalian Penyakit dan
Penyehatan Lingkungan, Kementrian Kesehatan RI.
King, P.D., Perry, M.C., 2001. Hepatotoxicity of Chemotherapy. The Oncologist 6: 162-176.
Kwara, A., Flanigan, T.P., Carter, E.J., 2005. Highly Active Antiretroviral Therapy (HAART) in Adults with Tuberculosis: Current Status. Int. J.
Tuberc. Lung Dis. 9(3): 248–257. Available from:
http://www.ingentaconnect.com/content/iuatld/ijtld/2005/00000009/0000000
35
3/art00005?token=005716cf4cd1ef405847447b49762f533f6a6f5b2b6747363 3757e6f4f2858592f3f3b57f6de05c29cb7b5b [Accessed 20 June 2015].
Navarro, V.J., Senior, J.R., 2006. Drug-Related Hepatotoxicity. N. Engl. J. Med. 354: 731-739.
Nelwan, A.R.P., Palar, S., Lombo, J.C.M., 2014. Kadar Serum Glutamic Oxaloacetat Transaminase dan Serum Glutamic Pyruvic Transaminase pada Pasien Tuberkulosis Paru Selama Dua Bulan Berjalannya Pemberian Obat Anti Tuberkulosis Kombinasi Dosis Tetap. Jurnal e-Clinic 2(3). Available from: http://ejournal.unsrat.ac.id/index.php/eclinic/article/view/6068/5580 [Accessed 9 November 2015].
Nishimura, Y., Kurata, N., Sakurai, E., Yasuhara, H., 2004. Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities. J.
Pharmacol. Sci. 96: 293–300.
PDPI, 2006. Pedoman Diagnosis Dan Penatalaksanaan Tuberkulosis Di
Indonesia. Available from: http://www.klikpdpi.com/konsensus/tb/tb.html
[Accessed 8 May 2015].
Sacher, R.A., McPhrerson, R.A., 2004. Tinjauan Klinis Hasil Pemeriksaan
Laboratorium. Edisi 11. Jakarta: EGC, 675.
Saukkonen, J.J., et al., 2006. An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. Am. J. Respir. Crit. Care Med. 174: 935-952.
Sherlock, S., Dooley, J., 2002. Diseases of the Liver and Biliary System. 11th ed. UK: Blackwell Publishing, 350.
36
Singh, G., Pitoyo, C.W., 2012. The Prevalence and Factors Associated with Drug-Induced Hepatitis in HIV-Positive Tuberculosis Patients. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy 13(2): 80-85. Available from: http://repository.uinjkt.ac.id/dspace/bitstream/123456789 /26410/1/Nurazminah Alwi-FKIK.pdf [Accessed 10 December 2015].
Soehardiman, D., Soepandi, P.Z., Nawas, A., 2008. Perbandingan Hasil Akhir Pengobatan OAT Kombinasi Dosis Tetap (KDT) dengan Kombipak pada Pengobatan TB Paru dengan Strategi DOTS. Jurnal Respirologi Indonesia 28 (3): 126-135.
Tariq, S., Khan, T.S., Malik, S., Anwar, M.S., Rashid, A., 2009. Frequency of Anti-Tuberculous Therapy-Induced Hepatotoxicity in Patients and Their Outcome. J Ayub Med Coll Abbottabad 21(4): 50-52. Available from: http://ayubmed.edu.pk/JAMC/PAST/21-4/Sumbal.pdf [Accessed 9 November 2015].
Tostmann, A., et al. 2008. Antituberculosis Drug-Induced Hepatotoxicity: Concise Up-to-Date Review. Journal of Gastroenterology and Hepatology 23: 192-202.
Wahyuni, A.R., 2007. Statistika Kedokteran (Disertai Aplikasi dengan SPSS). Jakarta: Bamboedoea Communication.
WHO, 1992. International Monitoring of Adverse Reactions to Drugs: Adverse
Reaction Terminology. Uppsala: WHO Collaborating Center for International
Drug Monitoring.
Wu, S.S., et al. 2012. Effect of Scheduled Monitoring of Liver Function During Anti-Tuberculosis Treatment in a Retrospective Cohort in China. BMC
Public Health 12: 454.
